These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4623595)

  • 1. Anorexigenic activity of intermittent dextroamphetamine with and without meprobamate.
    Noble RE
    Curr Ther Res Clin Exp; 1972 Apr; 14(4):162-7. PubMed ID: 4623595
    [No Abstract]   [Full Text] [Related]  

  • 2. A determination of the anorexigenic potential of dl-amphetamine, d-amphetamine, l-amphetamine and phentermine.
    Lawlor RB; Trivedi MC; Yelnosky J
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):401-7. PubMed ID: 5367311
    [No Abstract]   [Full Text] [Related]  

  • 3. Human drug discrimination: d-amphetamine and other anorectics.
    Chait LD; Uhlenhuth EH; Johanson CE
    NIDA Res Monogr; 1986; 67():161-7. PubMed ID: 3092063
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology of phentermine.
    Yelnosky J; Panasevich RE; Borrelli AR; Lawlor RB
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):62-76. PubMed ID: 5353475
    [No Abstract]   [Full Text] [Related]  

  • 5. Mazindol, a new non-amphetamine anorexigenic agent.
    Hadler AJ
    J Clin Pharmacol New Drugs; 1972; 12(11):453-8. PubMed ID: 4563662
    [No Abstract]   [Full Text] [Related]  

  • 6. Subjective effects of two anorexigenic agents--fenfluramine and AN 448 in normal subjects.
    Holmstrand J; Jonsson J
    Postgrad Med J; 1975; 51 Suppl 1():183-6. PubMed ID: 768967
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacodynamic study of amphetamine para-chlorophenoxyacetate].
    Vacher J; Lakatos C; Rispat G; Duchêne-Marullaz P
    Med Pharmacol Exp Int J Exp Med; 1966; 15(6):579-86. PubMed ID: 6013032
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical long-term testing of a new appetite depressant Ro 4-5282 (Pondinil)].
    Jenny S; Rhomberg F
    Schweiz Rundsch Med Prax; 1970 Jul; 59(28):1042-4. PubMed ID: 4934638
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trial of drugs (8): clinical evaluation of the ability of an appetite-reducing drug to stimulate the central nervous system].
    Gadd K; Gunne LM
    Lakartidningen; 1970 Jun; 67():Suppl II:100+. PubMed ID: 4920745
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of the activity oof 2 new anorectics].
    Rinetti M; Barbaresi F; Colombi L
    Schweiz Rundsch Med Prax; 1970 Apr; 59(17):633-7. PubMed ID: 4928198
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacologic study of fenfluramine and its optical isomers].
    Le Douarec JC; Schmitt H; Laubie M
    Arch Int Pharmacodyn Ther; 1966 May; 161(1):206-32. PubMed ID: 5941878
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacologic study of an anorexigenic agent: furfenorex].
    Boissier JR; Dumont C; Ratouis R; Moisy D
    Arch Int Pharmacodyn Ther; 1967 May; 167(1):150-62. PubMed ID: 6035092
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the testing of the central side-effects of appetite depressants].
    Klein K
    Med Klin; 1966 Sep; 61(35):1391-4. PubMed ID: 5998594
    [No Abstract]   [Full Text] [Related]  

  • 14. Sustained-action phendimetrazine in obesity.
    Hadler AJ
    J Clin Pharmacol J New Drugs; 1968; 8(2):113-7. PubMed ID: 4871210
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of pimetine with amphetamine and of tybamate with meprobamate.
    Hollister LE
    J New Drugs; 1966; 6(6):339-44. PubMed ID: 5976158
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study of the anorexigenic activity of 5-(3,4-dichlorophenoxymethyl)-2-amino-2-oxazoline HCl and d-amphetamine in different species.
    Abdallah AH
    Toxicol Appl Pharmacol; 1973 Jul; 25(3):344-53. PubMed ID: 4580493
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence that in rats 1-benzyl- -methoxy-3-trifluoromethylphenethylamine (SK& F 1-39728) dissociates anorexia from central stimulation and actions on brain monoamine stores.
    Groppetti A; Misher A; Naimzada M; Revuelta A; Costa E
    J Pharmacol Exp Ther; 1972 Sep; 182(3):464-73. PubMed ID: 5055405
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology of a halogenated aralkylamine with anorectic properties.
    Macko E; Saunders H; Heil G; Fowler P; Reichard G
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):102-17. PubMed ID: 4629973
    [No Abstract]   [Full Text] [Related]  

  • 19. The interaction of alcohol and meprobamate in man.
    Reisby N; Theilgaard A
    Acta Psychiatr Scand Suppl; 1969; 208():5-204. PubMed ID: 4906098
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of thiamine deficiency on the actions of drugs effecting the central nervous system.
    VanderWende C; Johnson JC; Spoerlein MT; Luc NC
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):513-25. PubMed ID: 4750100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.